Payroll Accounting Analyst
IBEX
Payroll Accounting Analyst
IBEX
Biotech company: antibodies and gene therapy
This is Work On Site in IBEX Paranaque (SM BF) and on a Night Shift.
What You'll Do:
Prepare and review journal entries from Workday for each payroll cycle, including wages, employer taxes, withholdings, and benefit deductions, in line with accounting standards.
Perform monthly accruals for payroll, bonuses, commissions, PTO, and employer taxes, working with People and business teams to capture obligations promptly.
Reconcile payroll register to GL and payroll bank activity, and resolve variances quickly.
Account for employee benefits, including self-funded health plan accruals, reserves, and true-ups, as well as 401(k) and other deductions.
Support stock-based compensation accounting and related payroll entries.
Prepare the monthly compensation and benefits variance analysis and maintain supporting schedules for the monthly financial package.
Support year-end payroll reconciliations and Canadian payroll accounting.
Assist with audit requests and help maintain SOX controls over payroll processes.
What We Look For:
Team player with strong interpersonal skills who works well with Payroll, People, Accounting, and management teams.
Effective written and verbal communication skills.
Close attention to detail and a track record of accurate, timely work.
Ability to adapt quickly to changing environments and a proactive approach to solving problems.
Strong knowledge of US GAAP, including accruals and compensation-related accounting (ASC 710, ASC 718).
Proficiency in Excel and accounting software/ERP; experience with Workday, NetSuite, and FloQast/Numeric is a plus.
2+ years of payroll accounting or general accounting experience; public accounting or CPA a plus.
Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.
Explore more opportunities at IBEX